Pentostatin

CHEMBL1580 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

268.3 g/mol

LogP

-2.1

Phase

4

This chemotherapy drug treats hairy cell leukemia by blocking an enzyme leukemia cells need to survive.

Berat Molekul

268,2700 g/mol

LogP

-2,10

TPSA

112,00 Å²

Lipinski RO5

Lulus

Area Terapeutik

Bladder Cancer Lymphoma HIV/AIDS Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O

InChI

InChI=1S/C11H16N4O4/c16-3-8-6(17)1-9(19-8)15-5-14-10-7(18)2-12-4-13-11(10)15/h4-9,16-18H,1-3H2,(H,12,13)/t6-,7+,8+,9+/m0/s1

Molecular Formula

C11H16N4O4

HBD / HBA

4 / 6

Ikatan yang Dapat Dirotasi

2

Atom Berat

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This chemotherapy drug treats hairy cell leukemia by blocking an enzyme leukemia cells need to survive.

Yes, Pentostatin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1580. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 439693. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Mencari informasi yang ramah bagi pasien?

Pentostatin di PillFYI

Struktur

Data Cepat

Rumus: C11H16N4O4
Sinonim: 1

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.